Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
REDWOOD CITY, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a ...
– FCX-007 well-tolerated through 12 weeks post-administration with encouraging safety and positive early trends ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email